Read the article: https://aws.amazon.com/blogs/industries/federated-learning-based-protein-language-models-with-apheris-on-aws/
In collaboration with AWS, we implemented FRA-LoRA (Full Rank Aggregation of Low-Rank Adapters) in a federated setting to fine-tune ESM-2 across multiple sites, all without sharing raw data. LoRA reduced trainable parameters to <2% of the original model, cutting communication overhead while preserving accuracy.

Read the article: https://aws.amazon.com/blogs/industries/federated-learning-based-protein-language-models-with-apheris-on-aws/

GEN published a thoughtful coverage of last month's Bio-IT World plenary keynote where JT from Apheris presented a session on federated learning and fine-tuning for drug discovery.

ADMET liabilities drive 40–45% of clinical attrition, and models break on novel chemistry which is precisely where chemists need them most. Pre-competitive federated networks address this through complementary data collaboration. A walk through the evidence behind the Apheris ADMET Network.

Federated techniques such as federated learning and federated analysis have emerged as a powerful paradigm for enabling multi-center research on sensitive clinical data while preserving patient privacy. In this study we provide a federated leraning framework for ML research.
NEWSLETTER
A quaterly briefing on operationalizing and customizing co-folding, ADMET and antibody developability models. Written by Robin Röhm, co-founder and CEO at Apheris.

Robin Röhm
Co-Founder & CEO
© 2026 Apheris AI GmbH. All rights reserved.